Selection of small peptides, inhibitors of translation.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2734330)

Published in J Mol Biol on July 02, 2009

Authors

Beatriz Llano-Sotelo1, Dorota Klepacki, Alexander S Mankin

Author Affiliations

1: Center for Pharmaceutical Biotechnology, University of Illinois, Chicago, 60607, USA.

Articles cited by this

Structures of the bacterial ribosome at 3.5 A resolution. Science (2005) 12.63

Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science (2001) 8.68

Arginine-mediated RNA recognition: the arginine fork. Science (1991) 3.89

A functional pseudoknot in 16S ribosomal RNA. EMBO J (1991) 3.59

The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol (2005) 3.27

Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit. Nature (1994) 2.96

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J Mol Biol (1999) 2.10

Managing antibiotic resistance. N Engl J Med (2000) 1.90

Drugs targeting the ribosome. Curr Opin Struct Biol (2005) 1.77

A ribosomal ambiguity mutation in the 530 loop of E. coli 16S rRNA. Nucleic Acids Res (1992) 1.76

Antibiotics and the ribosome. Mol Microbiol (2006) 1.71

In vitro reconstitution of 30S ribosomal subunits using complete set of recombinant proteins. Methods Enzymol (2000) 1.29

The ribosome-in-pieces: binding of elongation factor EF-G to oligoribonucleotides that mimic the sarcin/ricin and thiostrepton domains of 23S ribosomal RNA. Proc Natl Acad Sci U S A (1997) 1.26

Deleterious mutations in small subunit ribosomal RNA identify functional sites and potential targets for antibiotics. Proc Natl Acad Sci U S A (2005) 1.21

A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit. Proc Natl Acad Sci U S A (2001) 1.16

Mutations in the peptidyl transferase center of 23 S rRNA reveal the site of action of sparsomycin, a universal inhibitor of translation. J Mol Biol (1996) 1.12

RNA as a drug target: chemical, modelling, and evolutionary tools. Curr Opin Biotechnol (1998) 1.07

Potential new antibiotic sites in the ribosome revealed by deleterious mutations in RNA of the large ribosomal subunit. J Biol Chem (2007) 1.04

Structural basis for cross-resistance to ribosomal PTC antibiotics. Proc Natl Acad Sci U S A (2008) 1.04

Structural changes in the 530 loop of Escherichia coli 16S rRNA in mutants with impaired translational fidelity. Nucleic Acids Res (1995) 1.01

Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic. Proc Natl Acad Sci U S A (2005) 1.00

Novel antibacterial class. Antimicrob Agents Chemother (2003) 0.98

In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1978) 0.95

Functional effects of a G to U base change at position 530 in a highly conserved loop of Escherichia coli 16S RNA. Biochemistry (1993) 0.94

Structure of 23S rRNA hairpin 35 and its interaction with the tylosin-resistance methyltransferase RlmAII. EMBO J (2003) 0.93

Experimental models of protein-RNA interaction: isolation and analyses of tRNA(Phe) and U1 snRNA-binding peptides from bacteriophage display libraries. J Protein Chem (1999) 0.93

Structure of a conserved RNA component of the peptidyl transferase centre. Nat Struct Biol (1997) 0.92

Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr Med Chem (2006) 0.91

Novel tetrapeptide inhibitors of bacterial protein synthesis produced by a Streptomyces sp. Biochemistry (2006) 0.90

Combinatorial genetic technology for the development of new anti-infectives. Arch Pathol Lab Med (2004) 0.88

Fluorescently labeled ribosomes as a tool for analyzing antibiotic binding. RNA (2009) 0.87

Structure and function of the conserved 690 hairpin in Escherichia coli 16 S ribosomal RNA: analysis of the stem nucleotides. J Mol Biol (2000) 0.85

Structure-based design of agents targeting the bacterial ribosome. Bioorg Med Chem Lett (2003) 0.83

Characterization of GE82832, a peptide inhibitor of translocation interacting with bacterial 30S ribosomal subunits. RNA (2006) 0.80

Articles by these authors

Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol (2007) 3.47

The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell (2007) 2.93

Molecular mechanism of drug-dependent ribosome stalling. Mol Cell (2008) 2.62

Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Cell (2012) 2.57

Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc Natl Acad Sci U S A (2010) 2.38

Nascent peptide in the ribosome exit tunnel affects functional properties of the A-site of the peptidyl transferase center. Mol Cell (2011) 1.96

Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog (2008) 1.83

The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. EMBO J (2010) 1.67

The methyltransferase YfgB/RlmN is responsible for modification of adenosine 2503 in 23S rRNA. RNA (2007) 1.60

RlmN and Cfr are radical SAM enzymes involved in methylation of ribosomal RNA. J Am Chem Soc (2010) 1.60

Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. Antimicrob Agents Chemother (2008) 1.57

Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics. J Biol Chem (2003) 1.49

The ribosomal peptidyl transferase center: structure, function, evolution, inhibition. Crit Rev Biochem Mol Biol (2005) 1.42

Macrolide antibiotics: binding site, mechanism of action, resistance. Curr Top Med Chem (2003) 1.37

A protein component at the heart of an RNA machine: the importance of protein l27 for the function of the bacterial ribosome. Mol Cell (2005) 1.30

Chemical engineering of the peptidyl transferase center reveals an important role of the 2'-hydroxyl group of A2451. Nucleic Acids Res (2005) 1.29

Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. Antimicrob Agents Chemother (2010) 1.27

Essential mechanisms in the catalysis of peptide bond formation on the ribosome. J Biol Chem (2005) 1.23

Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Ann N Y Acad Sci (2011) 1.23

Deleterious mutations in small subunit ribosomal RNA identify functional sites and potential targets for antibiotics. Proc Natl Acad Sci U S A (2005) 1.21

Genetic environment and stability of cfr in methicillin-resistant Staphylococcus aureus CM05. Antimicrob Agents Chemother (2011) 1.21

Binding site of the bridged macrolides in the Escherichia coli ribosome. Antimicrob Agents Chemother (2005) 1.17

Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs. Diagn Microbiol Infect Dis (2003) 1.09

Induction of erm(C) expression by noninducing antibiotics. Antimicrob Agents Chemother (2007) 1.09

Role of antibiotic ligand in nascent peptide-dependent ribosome stalling. Proc Natl Acad Sci U S A (2011) 1.07

Potential new antibiotic sites in the ribosome revealed by deleterious mutations in RNA of the large ribosomal subunit. J Biol Chem (2007) 1.04

An indigenous posttranscriptional modification in the ribosomal peptidyl transferase center confers resistance to an array of protein synthesis inhibitors. J Mol Biol (2008) 1.04

Desmethyl Macrolide Analogues to Address Antibiotic Resistance: Total Synthesis and Biological Evaluation of 4,8,10-Tridesmethyl Telithromycin. ACS Med Chem Lett (2011) 1.03

Tools for characterizing bacterial protein synthesis inhibitors. Antimicrob Agents Chemother (2013) 1.01

Inactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistance. Antimicrob Agents Chemother (2011) 0.99

Low fitness cost of the multidrug resistance gene cfr. Antimicrob Agents Chemother (2011) 0.98

Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition. Nucleic Acids Res (2013) 0.97

SPARK--a novel method to monitor ribosomal peptidyl transferase activity. Biochemistry (2002) 0.89

Desmethyl Macrolides: Synthesis and Evaluation of 4,10-Didesmethyl Telithromycin. ACS Med Chem Lett (2012) 0.89

Fluorescently labeled ribosomes as a tool for analyzing antibiotic binding. RNA (2009) 0.87

The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147L. Antimicrob Agents Chemother (2012) 0.86

Structural signatures of antibiotic binding sites on the ribosome. Nucleic Acids Res (2010) 0.85

The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics. Proc Natl Acad Sci U S A (2010) 0.84

Desmethyl Macrolides: Synthesis and Evaluation of 4,8-Didesmethyl Telithromycin. ACS Med Chem Lett (2012) 0.83

Interactions of the TnaC nascent peptide with rRNA in the exit tunnel enable the ribosome to respond to free tryptophan. Nucleic Acids Res (2013) 0.83

Picky nascent peptides do not talk to foreign ribosomes. Proc Natl Acad Sci U S A (2011) 0.81

Deregulation of translation due to post-transcriptional modification of rRNA explains why erm genes are inducible. Nat Commun (2013) 0.80

Synthesis and antibacterial activity of desosamine-modified macrolide derivatives. Bioorg Med Chem Lett (2012) 0.78

Synthesis and biological investigation of new 4''-malonyl tethered derivatives of erythromycin and clarithromycin. Bioorg Med Chem Lett (2006) 0.75